Table 3 The correlation of LRRN4 expression and clinical characteristics in crc patients
From: Prognostic value and biological function of LRRN4 in colorectal cancer
Characteristics | LRRN4-Low (%) | LRRN4-High (%) | p value |
|---|---|---|---|
Gender | Â | Â | Â |
 Male | 17 (53.1) | 28 (57.1) | 0.820 |
 Female | 15 (46.9) | 21 (42.9) |  |
Age | Â | Â | Â |
 ≤ 65 | 19 (59.4) | 31 (63.3) | 0.816 |
 > 65 | 13 (40.6) | 18 (36.7) |  |
Overall survival status | Â | Â | Â |
 Alive | 22 (68.8) | 17 (34.7) | 0.003 |
 Death | 10 (31.2) | 32 (65.3) |  |
Progression-free survival status | Â | Â | Â |
 Progression-free | 20 (64.5) | 13 (39.4) | 0.051 |
 Progression | 11 (35.5) | 20 (60.6) |  |
Location | Â | Â | Â |
 Colon | 20 (62.5) | 37 (75.5) | 0.225 |
 Rectum | 12 (37.5) | 12 (24.5) |  |
Histological type | Â | Â | Â |
 Mucinous | 9 (29.0) | 17 (32.5) | 0.633 |
 Nonmucinous | 22 (71.0) | 32 (67.5) |  |
Pathologic stage-T | Â | Â | Â |
 T 1/2 | 6 (18.8) | 5 (10.2) | 0.328 |
 T 3/4 | 26 (81.3) | 44 (89.8) |  |
Pathologic stage-N | Â | Â | Â |
 N0 | 21 (65.6) | 16 (32.7) | 0.006 |
 N1/2 | 11 (34.4) | 33 (67.3) |  |
Pathologic stage-M | Â | Â | Â |
 M0 | 31 (96.9) | 41 (83.7) | 0.080 |
 M1 | 1 (3.1) | 8 (16.3) |  |
Pathologic stage | Â | Â | Â |
 Stage I | 5 (15.6) | 3 (6.1) | 0.005 |
 Stage II | 16 (50.0) | 10 (20.4) |  |
 Stage III | 10 (31.3) | 28 (57.2) |  |
 Stage IV | 1 (3.1) | 8 (16.3) |  |
Adjuvant chemoradiotherapy | Â | Â | Â |
 No | 8 (25.0) | 19 (38.8) | 0.234 |
 Yes | 24 (75.0) | 30 (61.2) |  |
Grade | Â | Â | Â |
 1/2 | 29 (93.5) | 42 (89.4) | 0.697 |
 3 | 2 (6.5) | 5 (10.6) |  |